AVIESAN – Kick-off Meeting REACTing
29-30 June 2015
Les Pensières” Fondation Mérieux-Conference Center, Veyrier du Lac – France
REsearch and ACTion targeting emerging infectious diseases (REACTing)
Dr V. Lotteau’s talk : “Response to Ebola : In vitro & in vivo experiments”
Read next in 'Events'
- The 2024 international workshop on Alport syndrome
- ENYO Pharma annonce un financement de Série C de 39 millions d'euros et l’autorisation de la FDA (IND) pour tester Vonafexor dans un essai clinique de Phase 2 pour les patients atteints du syndrome d'Alport
- 6th CKD Summit – Chronic Kidney Disease Drug Development
- ASN Kidney Week
- Alport Connect 2023, the annual Alport syndrome patient and family meeting in US